Nanoscale analysis of the effects of antibiotics and CX1 on a Pseudomonas aeruginosa multidrug-resistant strain

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Formosa, C ^a,b,c,d   Grare, M ^f   Jauvert, E ^a,b,c   Coutable, A ^a,b,c   Regnouf De Vains, J B ^d   Mourer, M ^d   Duval, R E ^d,e   Dague, E ^a,b,c  

^a LAAS CNRS   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e ABC PlatformH   (France)

^f Institut Federatif de Biologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMISTRY; CYTOLOGY; DRUG EFFECT; METHODOLOGY; MULTIDRUG RESISTANCE; NANOTECHNOLOGY; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROSCOPY, ATOMIC FORCE; NANOTECHNOLOGY; PSEUDOMONAS AERUGINOSA;

EID: 84866059120     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00575     Document Type: Article

References (49)

1. Taubes, G. The Bacteria fight back. Science 321, 356-361 (2008).
2. Payne, D. J. Desperately seeking new antibiotics. Science 321, 1644-1645 (2008).
3. Paterson, D. L. & Lipman, J. Returning to the pre-antibiotic era in the critically ill: The XDR problem. Crit. Care Med. 35, 1789-1791 (2007). (Pubitemid 46985895)
4. Lipsitch, M., Bergstrom, C. T. & Levin, B. R. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proc. Natl. Acad. Sci. USA 97, 1938-1943 (2000). (Pubitemid 30118547)
5. Hauser, A. R. & Ozer, E. A. Pseudomonas aeruginosa. Nat. rev. Microbiol. 9, Poster (2011).
6. Skiada, A., Markogiannakis, A., Plachouras, D. & Daikos, G. L. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 37, 187-193 (2011).
7. Lister, P. D.,Wolter, D. J. & Hanson, N. D. Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22, 582-610 (2009).
8. Strateva, T. & Yordanov, D. Pseudomonas aeruginosa: a phenomenon of bacterial resistance. J. Med. Microbiol. 59 (2009).
9. Breidenstein, E. B. M., de la Fuente-Núñez, C. & Hancock, R. E. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19, 419-426 (2011).
10. Mortensen, N. P. et al. Effects of colistin on surface ultrastructure and nanomechanics of Pseudomonas aeruginosa cells. Langmuir 25, 3728-3733 (2009).
11. Soon, R. L. et al. Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy. Int. J. Antimicrob. Agents 38, 493-501 (2011).
12. Yin, L. M., Edwards, M. A., Li, J., Yip, C. M. & Deber, C. M. Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J. Biol. Chem. 287, 7738-7745 (2012).
13. Mourer, M., Duval, R. E., Finance, C. & Regnouf-de-Vains, J.-B. Functional organisation and gain of activity: The case of the antibacterial tetra-paraguanidinoethyl- calix[4]arene. Bioorg. Med. Chem. Lett. 16, 2960-2963 (2006).
14. Grare, M. et al. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. J. Antimicrob. Chemother. 60, 575-581 (2007). (Pubitemid 47299871)
15. Grare, M. et al. In vitro mutation studies with a new promising compound, the para-guanidinoethylcalix[4]arene. Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-3951 (2008).
16. Binnig, G., Rohrer, H., Gerber, C. & Weibel, E. Tunneling through a controllable vacuum gap. Appl. Phys. Lett. 40, 178-180 (1982).
17. Binnig, G. & Quate, C. F. Atomic force microscope. Phys. rev. lett. 56, 930-933 (1986).
18. Muller, D. J., Helenius, J., Alsteens, D. & Dufrene, Y. F. Force probing surfaces of living cells to molecular resolution. Nat. Chem. Biol. 5, 383-390 (2009).
19. Dufrêne, Y. F. & Müller, D. J. Atomic Force Microscopy as a multifunctional molecular toolbox in nanobiotechnology. Nat. Nanotechnol. 3, 261-269 (2008). (Pubitemid 351668045)
20. Cross, S. E., Jin, Y.-S., Rao, J. & Gimzewski, J. K. Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2, 780-783 (2007). (Pubitemid 350223349)
21. Buzhynskyy, N., Girmens, J.-F., Faigle, W. & Scheuring, S. Human cataract lens membrane at subnanometer resolution. J. Mol. Biol. 374, 162-169 (2007). (Pubitemid 47600241)
22. Stolz, M. et al. Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy. Nat. Nanotechnol. 4, 186-192 (2009).
23. Liu, S. & Wang, Y. Application of AFM in microbiology: a review. Scanning 32, 61-73 (2010).
24. Dorobantu, L. S. & Gray, M. R. Application of atomic force microscopy in bacterial research. Scanning 32, 74-96 (2010).
25. Alsteens, D. et al. Organization of the mycobacterial cell wall: a nanoscale view. Pflugers Arch. 456, 117-125 (2008).
26. Francius, G., Domenech, O., Mingeot-Leclercq, M. P. & Dufrêne, Y. F. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin. J. Bact. 190, 7904-7909 (2008).
27. El Kirat, K., Burton, I., Dupres, V. & Dufrene, Y. F. Sample preparation procedures for biological atomic force microscopy. J. Microsc. 218, 199-207 (2005). (Pubitemid 40812394)
28. Formosa, C., Grare, M., Duval, R. E. & Dague, E. Nanoscale effects of antibiotics on P. aeruginosa. Nanomed. Nanotechnol. Biol. Med. 8, 12-16 (2012).
29. Francius, G. et al. Conformational analysis of single polysaccharide molecule on live bacteria. ACS Nano 2, 1921-1929 (2008).
30. Emerson Iv, R. J. & Camesano, T. A. On the importance of precise calibration techniques for an atomic force microscope. Ultramicroscopy 106, 413-422 (2006). (Pubitemid 43287027)
31. Dague, E., Jauvert, E. & Trevisiol, E. France Pointe de microscope à force atomique modifiée et biomodifiée, 2010 nu dépôt 10 579
32. Jauvert, E. et al. Probing single molecule interactions by AFM using biofunctionalized dendritips. Sens. Actuators B Chem. 168, 436-441 (2012).
33. Hardman, K. D. & Ainsworth, C. F. Structure of concanavalin A at 2.4-A resolution. Biochem. 11, 4910-4919 (1972 ).
34. Naismith, J. H. & Field, R. A. Structural Basis of Trimannoside Recognition by Concanavalin A. J. Biol. Chem. 271, 972-976 (1996). (Pubitemid 26034954)
35. Gupta, D., Dam, T. K., Oscarson, S. & Brewer, C. F. Thermodynamics of lectincarbohydrate interactions. J. Biol. Chem. 272, 6388-6392 (1997).
36. Moothoo, D. N. & Naismith, J. H. Concanavalin A distorts the beta-GlcNAc- (1-2)-Man linkage of beta-GlcNAc-(1-2)-alpha-Man-(1-3)-[beta- GlcNAc-(1-2)- alpha-Man-(1-6)]-Man upon binding. Glycobiol. 8, 173-181 (1998). (Pubitemid 28098218)
37. Fotiadis, D. Atomic force microscopy for the study of membrane proteins. Curr. Opin. Biotechnol. (In Press).
38. Francius, G. et al. Nanoscale membrane activity of surfactins: Influence of geometry, charge and hydrophobicity. Biochim. Biophys. Acta 1778, 2058-2068 (2008).
39. Prior, R. B. & Warner, J. F. Morphological alterations of Pseudomonas aeruginosa by ticarcillin: a scanning electron microscope study. Antimicrob. Agents Chemother. 6, 853-855 (1974).
40. Andre, G. et al. Imaging the nanoscale organization of peptidoglycan in living Lactococcus lactis cells. Nat. Commun. 1, 27 (2010).
41. Hayhurst, E. J., Kailas, L., Hobbs, J. K. & Foster, S. J. Cell wall peptidoglycan architecture in Bacillus subtilis. Proc. Natl. Acad. Sci. 105, 14603-14608 (2008).
42. Vollmer, W. & Seligman, S. J. Architecture of peptidoglycan: more data and more models. Trends Microbiol. 18, 59-66 (2010).
43. Jenssen, H., Hamill, P. & Hancock, R. E. W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491-511 (2006). (Pubitemid 44137212)
44. Finlay, B. B. & Hancock, R. E. W. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2, 497-504 (2004). (Pubitemid 39200016)
45. McPhee, J. B., Lewenza, S. & Hancock, R. E. W. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50, 205-217 (2003). (Pubitemid 37222798)
46. Hancock, R. E. W. & Patrzykat, A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2, 79-83 (2002). (Pubitemid 34649857)
47. Sautrey, G. et al. Membrane activity of tetra-p-guanidinoethylcalix[4] arene as a possible reason for its antibacterial properties.J. Phys. Chem. B 115, 15002-15012 (2011).
48. Francius, G., Tesson, B., Dague, E., Martin-Jézéquel, V. & Dufrêne, Y. F. Nanostructure and nanomechanics of live Phaeodactylum tricornutum morphotypes. Environ. Microbiol. 10, 1344-1356 (2008). (Pubitemid 351499250)
49. Hutter, J. L. & Bechhoefer, J. Calibration of Atomic Force Microscope tips. Rev. Sci. Instrum. 64, 1868 (1993).